• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number WCD 4000
Device Problem Signal Artifact/Noise (1036)
Patient Problems Bradycardia (1751); Ventricular Fibrillation (2130)
Event Date 03/16/2022
Event Type  Death  
Manufacturer Narrative
The electrode belt and monitor have not been recovered.The device flag data from the last download does not indicate any device malfunction.
 
Event Description
A us distributor contacted zoll to report that a patient passed away while wearing the lifevest on (b)(6) 2022.Review of the download data, indicates the patient received three appropriate treatments during vt/vf which converted the arrythmia to a slower rhythm.At 00:24:20, the patient received the first appropriate treatment.The patient's rhythm at the time of the treatment event was vt @ 210 bpm with motion artifact.The patient's post-shock rhythm was sinus tachycardia @ 100 bpm with pvcs and motion artifact.At 00:27:23, the patient received the second appropriate treatment.The patient's rhythm at the time of the treatment event was vf with motion artifact.The patient's post-shock rhythm was vt @ 240 bpm with motion artifact.At 00:27:58, the patient received the third appropriate treatment.The patient's rhythm at the time of the treatment event was vf with motion artifact.The patient's post-shock rhythm was asystole with intermittent cardiac activity and motion artifact for 15 seconds transitioning to sinus bradycardia @ 30 bpm with pvcs and hb.At 00:47:47, electrode belt was disconnected.Patient was last seen in bradycardia.The patient passed away on (b)(6) 2022.Reporting due to post-shock asystole on third treatment.Post-shock asystole is a known and potentially adverse outcome of defibrillation therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238 3495
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238 3495
Manufacturer Contact
steven kyle
121 gamma drive
pittsburgh, PA 15238-3495
4129683333
MDR Report Key13905000
MDR Text Key287926677
Report Number3008642652-2022-03055
Device Sequence Number1
Product Code MVK
UDI-Device Identifier00855778005005
UDI-Public00855778005005
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 03/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberWCD 4000
Device Catalogue Number10A0988
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/18/2022
Initial Date FDA Received03/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-